Designed to provide quick access to standards of care for infectious disease by focusing on selection, proper doses, costs, and side effects of antimicrobial agents, the 2005-2006 Pocket Book of Infectious Disease Therapy draws extensively from recommendations made by the Centers for Disease Control and Prevention, the Medical Letter on Drugs and Therapeutics, and from official statements of respected medical societies. Tabular material has been updated to include all newly approved antibiotics, as well as new recommendations for management. This edition includes topical issues such as MRSA (USA 300 strain), Avian influenza, Acinetobacter Hepatitis B virus (HBV), hepatitis C virus (HCV), and bioterrorism. It also contains the new guidelines for pyogenic meningitis, diabetic foot infections, healthcare associated pneumonia, surgical prophylaxis, fungal infections, bacteruria, and management of infections associated with international travel.

The Pocket Book is for use by doctors nurses and other health workers who are responsible for the care of young children at the first level referral hospitals. This second edition is based on evidence from several WHO updated and published clinical guidelines. It is for use in both inpatient and outpatient care in small hospitals with basic laboratory facilities and essential medicines. In some settings these guidelines can be used in any facilities where sick children are admitted for inpatient care. The Pocket Book is one of a series of documents and tools that support the Integrated Managem.

Based on key content from Red Book: 2006 Report of the Committee on Infectious Diseases, 27th Edition, the new Red Bookr Atlas is a useful quick reference tool for the clinical diagnosis and treatment of more than 75 of the most commonly seen pediatric infectious diseases. Includes more than 500 full-color images adjacent to concise diagnostic and treatment guidelines. Essential information on each condition is presented in the precise sequence needed in the clinical setting: Clinical manifestations, Etiology, Epidemiology, Incubation period, Diagnostic tests, Treatment

Conn's Current Therapy 2014 is an easy-to-use, in-depth guide to the latest advances in therapeutics for common complaints, acute disease and chronic illness. Family medicine experts, Drs. Edward T. Bope and Rick D. Kellerman present the expertise and knowledge of hundreds of skilled international leaders on evidence-based clinical management options. With key diagnostic points and treatment recommendation tables, you'll have access to the information you need to make accurate clinical decisions. Apply the proven treatment strategies of hundreds of top experts in family and internal medicine. Get quick access to critical information with "Current Diagnosis" and "Current Therapy" boxes at the beginning of each chapter as well as standardized diagnostic points and clinical recommendation tables.

Conn's Current Therapy 2010 provides concise and easy-to-use guidance on the latest advances in therapeutics for common complaints and diagnoses. Edward T. Bope, MD; Robert E. Rakel, MD; and Rick D. Kellerman offer their expertise and the knowledge of hundreds of skilled international leaders on the full range of evidence-based management options. Tap into recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much more to stay on top of current treatment practices. With the full text online at expertconsult.com, you'll have the information you need right at your fingertips for easy access! Provides access to the full contents of the text online at expertconsult.com. Discusses recent developments and thorough updates on myelodysplastic syndromes, psychocutaneous medicine, recently-approved and soon-to-be-approved drugs, and much so you can stay on top of current treatment practices. Contains important diagnostic criteria in each chapter because correct diagnoses lead to the delivery of effective treatment. Features acknowledged expert contributors for each chapter so you know that you are getting the best and most practical and accurate advice. Presents management methods used by international experts to provide you with best practices from around the world. Covers most common major presenting symptoms in a section on symptomatic care to assure that your patients can get the best possible treatment while tests are being performed. Incorporates the latest information on recently-approved and soon-to-be-approved drugs so you are aware of all treatment options. Includes the ICD-9 list of common diseases and codes on end papers to enable you and your staff to accurately code for reimbursement.

In 1901 Emil von Behring received the first Nobel Prize in med. for serum therapy against diphtheria, a disease that killed thousands of infants annually. Diphtheria serum was the first major cure of the bacteriological era and its develop. generated procedures for testing, standardizing, and regulating drugs. Emphasizes Behring's contrib. to the study of infectious disease, the formation of modern immunology, and research on remedies and vaccines against microbial infections. Explores his relations to the rival bacteriological schools of Robert Koch and Louis Pasteur, the emergent German pharmaceutical industry, and the institutionalization of experimental therapeutic research. Also contains translations of 13 key articles by Behring and his assoc.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.